Chong DQ, Toh XY, Ho IAw, Sia KC, Newman JP, Yulyana Y, Ng W-H, Lai SH, Ho MMf, Dinesh N, et al. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. BMC Cancer. 2015;15(1):255.